Members |
targetComponentId |
Premature abnormal placenta |
Premature aging of placenta |
Premature ejaculation |
Premature ejaculation |
prématurité du fœtus |
Prematurity of infant (disorder) |
symptôme prémenstruel |
Finding of menstrual bleeding |
Premenstrual tension |
Premenstrual tension syndrome |
Preoperative nursing procedure |
Preoperative care |
interventions préopératoires |
Preoperative procedure |
Preputial skin flap |
Skin flap (substance) |
Preretinal fibrosis |
Epiretinal membrane |
Prescription telephone order |
Prescription ordered by telephone |
Presence of complement |
Complement assay |
Presence of complement component 3 |
Complement assay |
Presence of complement component 4 |
Complement assay |
Presence of drugs of abuse |
Drug, confirmation assay |
Presence of heavy metal |
Heavy metal screen |
Presence of pesticide |
Pesticides screen |
Pressure controlled synchronized intermittent mandatory ventilation |
Synchronized intermittent mandatory ventilation - pressure-control pressure-support inflation (regime/therapy) |
Pressure controlled ventilation |
Positive pressure ventilation |
Pressure on artery |
Pressure - action |
Pressure on limb artery |
Pressure - action |
escarre de décubitus |
Pressure injury |
Pressure ulcer |
Pressure injury (morphologic abnormality) |
escarre de décubitus de stade 1 |
Pressure injury stage I (disorder) |
escarre de décubitus de stade 2 |
Pressure injury stage II (disorder) |
escarre de décubitus de stade 3 |
Pressure injury stage III |
escarre de décubitus de stade 4 |
Pressure injury stage IV (disorder) |
Previous arthroplasty hip NEC: [Conversion from hemi-] or [removal femoral head prosthesis] |
Removal of prosthesis of joint structures of hip |
Prevotella oulora |
Prevotella oulorum (organism) |
Prevotella ruminicola ss ruminicola |
Prevotella ruminicola |
Prevotella zoogleoformans |
Bacteroides zoogleoformans (organism) |
Prilocaine hydrochloride 1% injection solution vial |
Product containing precisely prilocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Prilocaine hydrochloride 4%/epinephrine 200,000 injection solution vial |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection |
Primary ameloblastic carcinoma |
Ameloblastic carcinoma (morphologic abnormality) |
Primary carcinoma of bone, connective tissue, skin and breast |
Carcinoma of bone, connective tissue, skin and breast |
Primary ciliary dyskinesia |
Immotile cilia syndrome |
Primary closure |
Closure - action |
Primary cutaneous B-cell lymphoma - category |
Primary cutaneous B-cell lymphoma |
Primary cutaneous T-cell lymphoma - category |
Primary cutaneous T-cell lymphoma (morphologic abnormality) |
Primary cutaneous anaplastic large cell B-cell lymphoma |
Primary cutaneous B-cell lymphoma (disorder) |
Primary cutaneous large T-cell lymphoma - category |
Primary cutaneous large T-cell lymphoma |
maladie primaire |
Disease |
Primary frambesia |
Initial lesion of yaws |
Primary intra-osseous carcinoma |
Odontogenic tumor, malignant |
Primary intraosseous squamous cell carcinoma derived from keratocystic odontogenic neoplasm |
Intraosseous squamous cell carcinoma derived from keratocystic odontogenic neoplasm (morphologic abnormality) |
Primary intraosseous squamous cell carcinoma derived from odontogenic cyst |
Intraosseous squamous cell carcinoma derived from odontogenic cyst |
Primary malignant Müllerian mixed neoplasm of cervix uteri |
Carcinosarcoma of cervix uteri (disorder) |
Primary malignant adenomatous neoplasm |
Malignant adenomatous neoplasm (morphologic abnormality) |
Primary malignant mixed Mullerian neoplasm of endometrium |
Carcinosarcoma of endometrium (disorder) |
Primary malignant neoplasm of ill-defined site |
Primary malignant neoplasm (disorder) |
Primary operation NOC |
Surgical procedure (procedure) |
Primary papule of pinta |
Pinta, primary lesion |
Primary repair of cleft palate, unspecified |
Primary repair of cleft palate (procedure) |
Primary repair of torn capsule of knee, collateral |
Procedure on knee joint |
Primary repair of torn capsule of knee, cruciate |
Procedure on knee joint |
Primary sarcoma |
Sarcoma (morphologic abnormality) |
Primary seminoma |
Malignant seminoma |
Primary solid type intraosseous squamous cell carcinoma |
Solid type intraosseous squamous cell carcinoma |
Primary synovial chondromatosis |
Chondromatosis |
Primary transvestism |
Primary transvestism (finding) |
Primate immunodeficiency virus |
Primate lentivirus group (organism) |
Primitive neuroectodermal tumor/Ewing's sarcoma TNM finding |
American Joint Committee on Cancer allowable value |
Probing - action |
Exploration - action |
Probiotic agent |
Microbial agent (substance) |
Problems affecting labor NOS - delivered |
Disorder of labor / delivery |
Problems affecting labor NOS unspecified |
Disorder of labor / delivery |
Problems affecting labor NOS with antenatal problem |
Disorder of labor / delivery |
Procainamide hydrochloride 250mg m/r tablet |
Procainamide only product in oral dose form |
Procainamide hydrochloride 250mg prolonged-release oral tablet |
Procainamide only product in oral dose form |
Procainamide hydrochloride 750mg m/r tablet |
Procainamide only product in oral dose form |
Procainamide hydrochloride 750mg prolonged-release oral tablet |
Procainamide only product in oral dose form |
Procaine hydrochloride 10% injection |
Procaine 100 mg/mL solution for injection |
Procaine hydrochloride 10% injection solution 2mL vial |
Procaine 100 mg/mL solution for injection |
Procaine hydrochloride 10mg/mL (1%) injection solution vial |
Product containing precisely procaine 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Procaine penicillin allergy |
Allergy to benzylpenicillin |
Procedure aiding diagnosis NOS |
Procedure |
Procedure aiding diagnosis NOS |
Procedure |
Procedure on anus |
Operation on anus |
Procedure on uvula (uvula palatina) |
Operation on uvula |
intervention axée sur une constatation clinique |
Procedure |
intervention relative à une intervention |
Procedure |
Prochlorperazine edisylate 5mg/5mL syrup |
Prochlorperazine 1 mg/mL oral solution |
Prodigiosin |
Prodigiosin |
Product containing acetylcholine in intraocular dose form (medicinal product form) |
Acetylcholine-containing product in parenteral dose form |
Product containing afamelanotide in subcutaneous dose form (medicinal product form) |
Product containing afamelanotide in parenteral dose form (medicinal product form) |
Product containing allantoin and coal tar |
Allantoin- and coal tar extract-containing product |
Product containing aluminium in oropharyngeal dose form (medicinal product form) |
Aluminium-containing product in oromucosal dose form |
Product containing aminosalicylic sodium |
Product containing para-aminosalicylic acid (medicinal product) |
Product containing ammonium thioglycolate |
Thioglycolic acid-containing product |
Product containing antitrypanosomal |
Antiprotozoal agent |
Product containing apomorphine in oropharyngeal dose form (medicinal product form) |
Product containing apomorphine in oromucosal dose form (medicinal product form) |
Product containing ascorbic acid in oropharyngeal dose form (medicinal product form) |
Product containing ascorbic acid in oromucosal dose form (medicinal product form) |
Product containing baloxavir marboxil (medicinal product) |
Baloxavir-containing product |
Product containing baloxavir marboxil in oral dose form (medicinal product form) |
Baloxavir-containing product in oral dose form |
Product containing benzalkonium in oropharyngeal dose form (medicinal product form) |
Benzalkonium-containing product in oromucosal dose form |
Product containing benzocaine in oropharyngeal dose form (medicinal product form) |
Benzocaine-containing product in oromucosal dose form |
Product containing beta-lactamase inhibitor (product) |
Beta-lactamase inhibitor antibacterial agent |
Product containing buprenorphine and naloxone in oropharyngeal dose form (medicinal product form) |
Product containing buprenorphine and naloxone in oromucosal dose form (medicinal product form) |
Product containing buprenorphine in oropharyngeal dose form (medicinal product form) |
Buprenorphine-containing product in oromucosal dose form |
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
Carmellose- and hydroxyapatite-containing product |
Product containing calcium lactate and carob |
Product containing calcium lactate (medicinal product) |
Product containing calcium leucovorin |
Product containing folinic acid (medicinal product) |